VTRS
Price
$10.19
Change
-$0.27 (-2.58%)
Updated
Nov 20 closing price
Capitalization
11.71B
101 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

VTRS

Header iconVTRS Comparison
Open Charts VTRSBanner chart's image
Viatris
Price$10.19
Change-$0.27 (-2.58%)
Volume$8.67M
Capitalization11.71B
VTRS Comparison Chart in %
VTRS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Bausch Health Companies (NYSE:BHC), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.06B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was -4%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was 26%. RGTLF experienced the highest price growth at 66%, while TSNDF experienced the biggest fall at -38%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was 27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 62
Price Growth Rating: 60
SMR Rating: 79
Profit Risk Rating: 90
Seasonality Score: 0 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Nov 21, 2025
Stock price -- (VTRS: $10.17)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VTRS’s FA Score shows that 2 FA rating(s) are green while.

  • VTRS’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VTRS’s TA Score shows that 5 TA indicator(s) are bullish.

  • VTRS’s TA Score: 5 bullish, 5 bearish.

Price Growth

VTRS (@Pharmaceuticals: Generic) experienced а -6.78% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.18%. For the same industry, the average monthly price growth was -7.61%, and the average quarterly price growth was +25.85%.

Reported Earning Dates

VTRS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.18% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS
Capitalization11.7B
EBITDA-493.3M
Gain YTD-15.148
P/E Ratio236.20
Revenue14.1B
Total Cash809M
Total Debt14.8B
FUNDAMENTALS RATINGS
VTRS: Fundamental Ratings
VTRS
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VTRS
RSI
ODDS (%)
Bearish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
50%
Momentum
ODDS (%)
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bearish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 11 days ago
68%
Declines
ODDS (%)
Bearish Trend 1 day ago
66%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
53%
Aroon
ODDS (%)
Bullish Trend 1 day ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
VTRS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LMUB50.67-0.13
-0.26%
iShares Long-Term National Muni Bd ETF
FCT9.46-0.06
-0.68%
First Trust Senior Floating Rate Income Fund II
BUFY21.45-0.15
-0.68%
FT Vest Laddered Intl Mod Buffr ETF
FLSW38.45-0.45
-1.17%
Franklin FTSE Switzerland ETF
RYLD14.78-0.25
-1.66%
Global X Russell 2000 Covered Call ETF

VTRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-2.77%
ELAN - VTRS
49%
Loosely correlated
-1.03%
AMPH - VTRS
48%
Loosely correlated
N/A
AMRX - VTRS
45%
Loosely correlated
N/A
ZTS - VTRS
39%
Loosely correlated
-1.02%
ALKS - VTRS
37%
Loosely correlated
-1.69%
More